Invivyd reports sustained neutralization activity of PEMGARDA™ against dominant SARS-CoV-2 variants, supporting its ongoing emergency use status. Quiver AI Summary Invivyd, Inc. announced new in vitro ...
Invivyd, Inc. has announced new in vitro data showing that its monoclonal antibody PEMGARDA™ (pemivibart) maintains effective neutralizing activity against the prevalent LP.8.1 variant of SARS-CoV-2, ...
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™ (pemivibart) against XEC Centers for Disease Control reports XEC and KP.3.1.1 (previously disclosed as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results